Different therapeutic responses in chronic obstructive pulmonary disease subgroups

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 8, 2011, Pages 1104-1110

  Lee, J S ^a   Huh, J W ^a   Chae, E J ^a   Seo, J B ^a   Ra, S W ^b   Lee, J H ^c,g   Kim, E K ^c   Lee, Y K ^d   Kim, T H ^e   Kim, W J ^f   Lee, S M ^h,i   Lee, S ^j   Lim, S Y ^k   Shin, T R ^l   Yoon, H I ^m   Sheen, S S ⁿ   Oh, Yeon Mok ^a   Lee, Sang Do ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Ulsan University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

^e Hanyang University Guri Hospital   (South Korea)

^f Kangwon National University   (South Korea)

^g Mokdong Hospital   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

ⁱ Seoul National University Hospital   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k Sungkyunkwan University School of Medicine   (South Korea)

^l Hallym University College of Medicine   (South Korea)

^m Seoul National University Bundang Hospital   (South Korea)

ⁿ Ajou University School of Medicine   (South Korea)

more..

Author keywords

COPD; Diffusing capacity; Emphysema; Lung volume

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE PLUS FORMOTEROL; CARBON MONOXIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; TOTAL LUNG CAPACITY; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RESIDUAL VOLUME; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 79960426876     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0553     Document Type: Article

References (31)

1. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
2. Friedlander A L, Lynch D, Dyar L A, Bowler R P. Phenotypes of chronic obstructive pulmonary disease. COPD 2007; 4: 355-384. (Pubitemid 350135871)
3. Calverley P M A, Pauwels R A, Jones P W, Anderson J A, Vestbos J. The severity of airways obstruction as a determinant of treatment response in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 209-218.
4. Jenkins C R, Jones P W, Calverley P M A, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009; 10: 59.
5. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-1108.
6. Boschetto P, Miniati M, Miotto D, et al. Predominant emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 2003; 21: 450-454. (Pubitemid 36336203)
7. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med 2006; 100: 1742-1752. (Pubitemid 44283760)
8. Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62: 932-937. (Pubitemid 350084489)
9. Lee J H, Lee Y K, Kim E K, et al. Responses to inhaled longacting beta-agonist and corticosteroid according to COPD subtype. Respir Med 2010; 104: 542-549.
10. Kinsella M, Muller N L, Abboud R T, Morrison N J, Dybuncio A. Quantitation of emphysema by computed tomography using a 'density mask' program and correlation with pulmonary function tests. Chest 1990; 97: 315-321.
11. Madani A, Keyzer C, Gevenois P A. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001; 18: 720-730. (Pubitemid 33040632)
12. Leith D E, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J 1999; 13: 468-472. (Pubitemid 29086854)
13. Lee Y K, Oh Y M, Lee J H, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186: 157-165.
14. Kim W J, Oh Y M, Sung J, et al. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung 2008; 186: 381-386.
15. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of a CIBA guest symposium. Thorax 1959; 14: 286-299.
16. Choi J K, Paek D Y, Lee J O. Normal predicted values of spirometry in Korean population. Tuberc Respir Dis 2005; 58: 230-242. (Pubitemid 40791363)
17. Park J O, Choi I S, Park K O. Normal predicted standards of single breath carbon monoxide diffusing capacity of lung in healthy nonsmoking adults. Korean J Med 1985; 28: 176-183.
18. Quanjer P H. Standardized lung function testing. Working Party Report 'Standardisation of lung function test', European Community for Steel and Coal. Bull Eur Physiopathol Respir 1983; 19 (Suppl 5): S1-S95.
19. Lee J S, Ra S W, Chae E J, et al. Validation of the lower limit of normal diffusing capacity for detecting emphysema. Respiration 2011; 81: 287-293.
20. Gevenois P, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-657.
21. Wood S A, Zerhouni E A, Hoford J D. Hoffiman E A, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995; 79: 1687-1697.
22. Celli B R, Thomas N E, Anderson J A, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-338.
23. Wedzicha J A, Calverley P M A, Seemungal T A, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177: 19-26.
24. Patel B D, Coxson H O, Pillai S G, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 500-505.
25. Mahler D A, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 467-470.
26. Foglio K, Carone M, Pagani M, et al. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir Med 2000; 94: 256-263. (Pubitemid 30198076)
27. Casanova C, Cote C, de Torres J P, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597. (Pubitemid 40365414)
28. O'Donnell D E, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 100: 61-67. (Pubitemid 47035703)
29. Newton M F, O'Donnell D E, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121: 1042-1050. (Pubitemid 34280421)
30. Song E H, Oh Y M, Hong S B, et al. Selection of reference equations for lung volumes and diffusing capacity in Korea. Tuberc Respir Dis 2006; 61: 218-226. (Pubitemid 44870548)
31. Han M K, Postma D, Mannino D M, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176: 1179-1184. (Pubitemid 350256470)